×

Use of NRG4, or inhibitors thereof, in the treatment of colon and pancreatic cancers

  • US 7,198,899 B2
  • Filed: 06/03/2003
  • Issued: 04/03/2007
  • Est. Priority Date: 06/03/2002
  • Status: Expired due to Fees
First Claim
Patent Images

1. A method of diagnosing colon cancer in a patient, said method comprising:

  • (a) contacting a polynucleotide that binds to mRNA encoding an NRG4 polypeptide comprising the amino acid sequence of SEQ ID NO;

    2 with nucleic acids of a biological sample acquired from said patient under binding conditions suitable to form a duplex; and

    (b) comparing the amount of the duplex formed to the amount of duplex formed when the polynucleotide is contacted with nucleic acids of a biological sample acquired from a normal control,wherein increased levels of the amount of duplex formed upon contacting said polynucleotide and said nucleic acids of the biological sample acquired from said patient compared to the amount of duplex formed upon contacting said polynucleotide and said nucleic acids of the biological sample acquired from a normal control is indicative of the presence of colon cancer in said patient.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×